Harmful to fetal development? FDA warns of adverse reproductive effects of vinpocetine

The warning is part of the US agency’s continued efforts to provide guidance and clarity in the expanding dietary supplement market

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

25 Jun 2019 --- With two-thirds of consumers in Europe and the US saying that digestive health is very important to them, products that tout gut-health continue to be on trend. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

21 Jun 2019 --- In nutrition news this week, the US Food and Drug Administration (FDA) has clarified its Nutrition Facts labels guidance regarding the “Added Sugars”... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

07 Jun 2019 --- In nutrition news this week, Coeliac UK and Innovate UK announced a £180k (US$229k) funding competition for research into celiac disease, while Gelita’s... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

07 Jun 2019 --- Severe medical events as a result of dietary supplement use – sold for weight loss, sexual function, muscle building and energy – are experienced by... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

01 May 2019 --- Biotechnology company Gelesis’ weight management prescription drug, Plenity, has been cleared by the US Food and Drug Administration (FDA) for use in obese... Read More